Literature DB >> 19521422

MicroRNAs and glioblastoma; the stem cell connection.

J Godlewski1, H B Newton, E A Chiocca, S E Lawler.   

Abstract

Recent data draw close parallels between cancer, including glial brain tumors, and the biology of stem and progenitor cells. At the same time, it has become clear that one of the major roles that microRNAs play is in the regulation of stem cell biology, differentiation, and cell 'identity'. For example, microRNAs have been increasingly implicated in the regulation of neural differentiation. Interestingly, initial studies in the incurable brain tumor glioblastoma multiforme strongly suggest that microRNAs involved in neural development play a role in this disease. This encourages the idea that certain miRs allow continued tumor growth through the suppression of differentiation and the maintenance of the stem cell-like properties of tumor cells. These concepts will be explored in this article.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521422     DOI: 10.1038/cdd.2009.71

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  53 in total

Review 1.  Molecular heterogeneity of glioblastoma and its clinical relevance.

Authors:  Katalin Eder; Bernadette Kalman
Journal:  Pathol Oncol Res       Date:  2014-08-27       Impact factor: 3.201

2.  Glucose-based regulation of miR-451/AMPK signaling depends on the OCT1 transcription factor.

Authors:  Khairul I Ansari; Daisuke Ogawa; Arun K Rooj; Sean E Lawler; Anna M Krichevsky; Mark D Johnson; E Antonio Chiocca; Agnieszka Bronisz; Jakub Godlewski
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

Review 3.  Integration and analysis of genome-scale data from gliomas.

Authors:  Gregory Riddick; Howard A Fine
Journal:  Nat Rev Neurol       Date:  2011-07-05       Impact factor: 42.937

4.  MicroRNA-146a inhibits glioma development by targeting Notch1.

Authors:  Jie Mei; Robert Bachoo; Chun-Li Zhang
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

Review 5.  Brain tumor stem cells: Molecular characteristics and their impact on therapy.

Authors:  David L Schonberg; Daniel Lubelski; Tyler E Miller; Jeremy N Rich
Journal:  Mol Aspects Med       Date:  2013-07-04

6.  Reductions in the expression of miR-124-3p, miR-128-1, and miR-221-3p in pediatric astrocytomas are related to high-grade supratentorial, and recurrent tumors in Mexican children.

Authors:  Pilar Eguía-Aguilar; Mario Pérezpeña-Díazconti; Eduardo Benadón-Darszon; Fernando Chico-Ponce de León; Luis Gordillo-Domínguez; Samuel Torres-García; Stanislaw Sadowinski-Pine; Francisco Arenas-Huertero
Journal:  Childs Nerv Syst       Date:  2014-04-10       Impact factor: 1.475

7.  Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1.

Authors:  Agnieszka Bronisz; Yan Wang; Michal O Nowicki; Pierpaolo Peruzzi; Khairul Ansari; Daisuke Ogawa; Leonora Balaj; Gianluca De Rienzo; Marco Mineo; Ichiro Nakano; Michael C Ostrowski; Fred Hochberg; Ralph Weissleder; Sean E Lawler; E Antonio Chiocca; Jakub Godlewski
Journal:  Cancer Res       Date:  2013-12-05       Impact factor: 12.701

Review 8.  Tumor-initiating and -propagating cells: cells that we would like to identify and control.

Authors:  Berit Bølge Tysnes
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

9.  Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting.

Authors:  Elizabeth J Kelly; Rebecca Nace; Glen N Barber; Stephen J Russell
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

10.  MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.

Authors:  Alfredo Conti; Sara G Romeo; Annamaria Cama; Domenico La Torre; Valeria Barresi; Gaetana Pezzino; Chiara Tomasello; Salvatore Cardali; Filippo F Angileri; Francesca Polito; Guido Ferlazzo; Rosamaria Di Giorgio; Antonino Germanò; M'hammed Aguennouz
Journal:  Tumour Biol       Date:  2016-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.